FDA Import Refusal 1FX-6298101-4/10002/1 — Ipca Laboratories
The FDA refused shipment 1FX-6298101-4/10002/1 from Ipca Laboratories (India) on Jul 23, 2026. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 23, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 75